With a rich array of pre-clinical data, the Newton Knee is at the forefront of Exactech’s focus to improve clinical outcomes by utilizing soft tissue balancing technology in total knee replacement patients.
The studies were presented at the 2022 International Society for Computer Assisted Orthopaedic Surgery (CAOS) annual meeting.
An innovative, next-generation shoulder implant designed to improve glenoid fixation in anatomic total shoulder arthroplasty.
Exactech, a minority shareholder of JointMedica Limited, is collaborating with the United Kingdom-based orthopaedic device designer and manufacturer to deliver the next generation of hip resurfacing to the global market, and holds exclusive global distribution rights to the product.
This study, published in Foot & Ankle Surgery: Technique, Reports & Cases in March, is the Vantage Ankle’s third outcome publication but the first for its fixed bearing total ankle arthroplasty system.
The Equinoxe® reverse prosthesis is a groundbreaking implant that has served as the platform for several additional innovations in reverse shoulder arthroplasty.
United States Patent and Trademark Office (USPTO) has issued U.S. Patent #11,278,338 for the Newton™ Knee, a dynamic platform of cutting-edge technology used with forward-thinking implants that are designed to provide optimal balance in a reproducible way.
Surgeon attendees will be able to experience all the innovations through product demonstrations and an immersive experience in the technology suite.
the initial release of exacCoach™ with an automated patient text messaging service that helps surgeons easily communicate with their total joint patients from surgical preparation through rehabilitation.
Nancy Walsh
Senior Marketing Communications Director
media@exac.com
352-377-1140
Courtney Adkins
Marketing Communications Director
media@exac.com
352-377-1140
